Ryoichi Kurisaki¹, Daijiro Kabata², Hiroyuki Ida³, Masaki Arai³, Mihoko Ota³, Ayumi Shintani², Yoshihiko Furusawa³ (1.Department of Neurology, National Hospital Organization Kumamoto Saishun Medical Center, Japan, 2.Osaka Metropolitan University, Japan, 3.Japan Medical Office, Takeda Pharmaceutical Co. Ltd., Japan)

Takashi Kageyama (Department of Neurology, Tokai Memorial Hospital, Japan)

Eriko Imai¹, Katsunori Yokoi¹, Masashi Tsuzimoto², Keisuke Suzuki², Akiko Yamaoka¹, Kentaro Horibe¹, Akinori Takeda¹, Yutaka Arahata¹, Yukihiko Washimi^1,3 (1.Department of Neurology, National Center for Geriatrics and Gerontology, Japan, 2.Innovation Center for Translational Research, National Center for Geriatrics and Gerontology, Japan, 3.Obu Center for Dementia Care Research and Training, Japan)

Takahiko Murata^1,2, Satoko Obara¹, Masahiro Kawashima² (1.Department of Neurology, National Hospital Organization Morioka Medical Center, Japan, 2.Department of Neurology, Iwate Prefectural Ninohe Hospital, Japan)

Etsuro Mori¹, Manabu Ikeda², Tomoyuki Orimo³, Tomomi Yamada⁴, Osamu Konishi⁵ (1.Behavioral Neurology & Neuropsychiatry, Osaka University UGSCD, Japan, 2.Psychiatry, Osaka University Graduate School of Medicine, Japan, 3.Kmiyoga Setagayadori Clinic, Japan, 4.Data Center, Department of Medical Innovation, Osaka University Hospital, Japan, 5.Medical Affairs, Sumitomo Pharma, Japan)